Evidence map›Paper›PMID 24298555›Full record

ArticleBioMed research international2013

An influence of immunomodulation on Th1 and Th2 immune response in endometriosis in an animal model.

K Szymanowski, J Niepsuj-Biniaś, A Dera-Szymanowska, M Wołuń-Cholewa, A Yantczenko, E Florek, T Opala, M Murawski, K Wiktorowicz

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Immunology and Immunotherapy of Endometriosis.Journal of clinical medicine · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

K SzymanowskiDepartment of Mother's and Child's Health, K. Marcinkowski University of Medical Sciences, Polna Street 33, 60-535 Poznań, Poland.
J Niepsuj-Biniaś
A Dera-Szymanowska
M Wołuń-Cholewa
A Yantczenko
E Florek
T Opala
M Murawski
K Wiktorowicz
Poznan University of Medical Sciences · PLWroclaw Medical University · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimTo assess the role of the Th1 and Th2 cellular response in the etiology of endometriosis observed in a rat model, with the use of the RESAN immunomodulator. MATERIALS AND

methodsA comparative analysis of cytokines in blood serum typical of Th1 (TNF-α and INF-γ ) and Th2 (IL-4, IL-6, IL-10) cell response in groups of rats, in which RESAN preparation was used as prophylaxis (Gr. I) or treatment (Gr. II) of endometriosis.

resultsThe results indicated an increase in the level of cytokines in blood serum typical of Th2 cell response by comparing the second and third stages of the experiment in the second group of rats and a decrease in IL-4 and IL-10 between III and IV stages. There was a significant difference in cytokine levels during the third stage of the experiment by comparing I and II groups of rats. In the III group of rats, levels of IL-10 significantly increased between the II and III stages of the experiment.

conclusionRESAN preparation shows Th2 cell response, inhibiting the development of endometriosis in a rat model. Due to successful prophylactic action, one may speculate that RESAN vaccine may be effective as a complementary treatment after surgical excision.

Indexed as

ImmunomodulationAnimalsCancer VaccinesDisease Models, AnimalEndometriosisFemaleImmunologic FactorsInterferon-gammaInterleukin-10Interleukin-4Interleukin-6RatsRats, WistarTh1 CellsTh2 CellsTumor Necrosis Factor-alphaCancer VaccinesImmunologic FactorsInterferon-gammaInterleukin-10Interleukin-4Interleukin-6RESAN vaccineTumor Necrosis Factor-alpha

Identifiers

PMID24298555
PMCPMC3835717
OpenAlexW2141799028

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.